|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Stock-based compensation expense | |||||
| Unrealized net loss (gain) on natural gas derivatives | |||||
| Impairment of equity method investment in PLNL | |||||
| Unrealized gain on embedded derivative | |||||
| U.K. goodwill impairment | |||||
| U.K. long-lived and intangible asset impairment | |||||
| Loss on debt extinguishment | |||||
| Asset impairment | |||||
| Pension settlement loss | |||||
| Gain on sale of emission credits | |||||
| Loss on disposal of property, plant and equipment | |||||
| Loss on sale of Ince facility | |||||
| Undistributed (earnings) loss of affiliate—net of taxes | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable—net | |||||
| Inventories | |||||
| Accrued and prepaid income taxes | |||||
| Accounts payable and accrued expenses | |||||
| Customer advances | |||||
| Other—net | |||||
| Net cash provided by operating activities | |||||
| Investing Activities: | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchase of Waggaman ammonia production facility | |||||
| Distributions received from unconsolidated affiliate | |||||
| Purchase of investments held in nonqualified employee benefit trust | |||||
| Proceeds from sale of investments held in nonqualified employee benefit trust | |||||
| Proceeds from sale of Ince facility | |||||
| Purchase of emission credits | |||||
| Proceeds from sale of emission credits | |||||
| Other—net | |||||
| Net cash used in investing activities | |||||
| Financing Activities: | |||||
| Payments of long-term borrowings | |||||
| Payment to CHS related to credit provision | |||||
| Proceeds from long-term borrowings | |||||
| Repayments of short-term borrowings | |||||
| Financing fees | |||||
| Dividends paid on common stock | |||||
| Contributions from noncontrolling interests | |||||
| Distributions to noncontrolling interests | |||||
| Purchases of treasury stock | |||||
| Proceeds from issuances of common stock under employee stock plans | |||||
| Cash paid for shares withheld for taxes | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...